

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 5.53633978 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.53633978 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.53633978 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.53633978 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.53633978 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.53633978 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.06579561 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.06579561 |
| 9 | positive regulation of interferon-alpha production (GO:0032727) | 5.01906989 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.88607810 |
| 11 | regulation of interferon-alpha production (GO:0032647) | 4.75916232 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.71504827 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.47103041 |
| 14 | response to type I interferon (GO:0034340) | 4.37765077 |
| 15 | cellular response to type I interferon (GO:0071357) | 4.36274738 |
| 16 | type I interferon signaling pathway (GO:0060337) | 4.36274738 |
| 17 | negative regulation of interleukin-12 production (GO:0032695) | 4.23736420 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 4.16974425 |
| 19 | negative regulation of cell killing (GO:0031342) | 4.10077468 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.10077468 |
| 21 | response to host immune response (GO:0052572) | 3.86357697 |
| 22 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.86357697 |
| 23 | response to interferon-alpha (GO:0035455) | 3.74014931 |
| 24 | response to peptidoglycan (GO:0032494) | 3.70255460 |
| 25 | regulation of cholesterol storage (GO:0010885) | 3.62527042 |
| 26 | cellular response to interferon-alpha (GO:0035457) | 3.59366808 |
| 27 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.53085631 |
| 28 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.52112820 |
| 29 | response to host (GO:0075136) | 3.52112820 |
| 30 | response to host defenses (GO:0052200) | 3.52112820 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 3.48252845 |
| 32 | low-density lipoprotein particle clearance (GO:0034383) | 3.45957116 |
| 33 | positive regulation of interferon-beta production (GO:0032728) | 3.42070823 |
| 34 | microglial cell activation (GO:0001774) | 3.38895438 |
| 35 | neutrophil activation involved in immune response (GO:0002283) | 3.35948631 |
| 36 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.34126051 |
| 37 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.33898791 |
| 38 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.31039615 |
| 39 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.30913340 |
| 40 | positive regulation of antigen processing and presentation (GO:0002579) | 3.28712941 |
| 41 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.26513391 |
| 42 | detection of other organism (GO:0098543) | 3.26071741 |
| 43 | germinal center formation (GO:0002467) | 3.23276973 |
| 44 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.20623757 |
| 45 | response to muramyl dipeptide (GO:0032495) | 3.20122886 |
| 46 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.19090619 |
| 47 | natural killer cell mediated immunity (GO:0002228) | 3.18938656 |
| 48 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.18938656 |
| 49 | T-helper 1 type immune response (GO:0042088) | 3.18126636 |
| 50 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.17696894 |
| 51 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.16917499 |
| 52 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.16299591 |
| 53 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.16144543 |
| 54 | negative regulation of T cell mediated immunity (GO:0002710) | 3.11671966 |
| 55 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.11553760 |
| 56 | T cell migration (GO:0072678) | 3.10973425 |
| 57 | cellular response to virus (GO:0098586) | 3.10738798 |
| 58 | positive regulation of type 2 immune response (GO:0002830) | 3.06374217 |
| 59 | response to protozoan (GO:0001562) | 3.06326720 |
| 60 | apoptotic cell clearance (GO:0043277) | 3.05534105 |
| 61 | negative regulation of viral genome replication (GO:0045071) | 3.04360186 |
| 62 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.03452098 |
| 63 | regulation of T cell tolerance induction (GO:0002664) | 3.03257164 |
| 64 | detection of bacterium (GO:0016045) | 3.00707496 |
| 65 | I-kappaB phosphorylation (GO:0007252) | 3.00249065 |
| 66 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.99209742 |
| 67 | detection of external biotic stimulus (GO:0098581) | 2.98127647 |
| 68 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.92518824 |
| 69 | negative regulation of lipid storage (GO:0010888) | 2.90840919 |
| 70 | tolerance induction (GO:0002507) | 2.89088812 |
| 71 | macrophage activation (GO:0042116) | 2.88111887 |
| 72 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.87753036 |
| 73 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.87507165 |
| 74 | myeloid dendritic cell activation (GO:0001773) | 2.85779481 |
| 75 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.85368991 |
| 76 | leukocyte aggregation (GO:0070486) | 2.84184535 |
| 77 | cellular extravasation (GO:0045123) | 2.84148307 |
| 78 | regulation of chronic inflammatory response (GO:0002676) | 2.83472377 |
| 79 | respiratory burst (GO:0045730) | 2.82608249 |
| 80 | regulation of vitamin metabolic process (GO:0030656) | 2.80135398 |
| 81 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.79680446 |
| 82 | regulation of type 2 immune response (GO:0002828) | 2.79607624 |
| 83 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.77427938 |
| 84 | positive regulation of interleukin-12 production (GO:0032735) | 2.77119496 |
| 85 | regulation of tolerance induction (GO:0002643) | 2.76463504 |
| 86 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.75997622 |
| 87 | growth hormone receptor signaling pathway (GO:0060396) | 2.75796686 |
| 88 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.73397223 |
| 89 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.69251907 |
| 90 | regulation of antigen processing and presentation (GO:0002577) | 2.69221621 |
| 91 | regulation of necroptotic process (GO:0060544) | 2.67857688 |
| 92 | granulocyte activation (GO:0036230) | 2.67808452 |
| 93 | regulation of RIG-I signaling pathway (GO:0039535) | 2.67327251 |
| 94 | myeloid cell activation involved in immune response (GO:0002275) | 2.67276036 |
| 95 | regulation of response to interferon-gamma (GO:0060330) | 2.66550627 |
| 96 | response to interleukin-15 (GO:0070672) | 2.65732384 |
| 97 | regulation of regulatory T cell differentiation (GO:0045589) | 2.64980396 |
| 98 | interferon-gamma secretion (GO:0072643) | 2.64352470 |
| 99 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.64304986 |
| 100 | response to interferon-gamma (GO:0034341) | 2.63082475 |
| 101 | regulation of interferon-beta production (GO:0032648) | 2.61708343 |
| 102 | positive regulation of tolerance induction (GO:0002645) | 2.61110185 |
| 103 | myeloid dendritic cell differentiation (GO:0043011) | 2.61058344 |
| 104 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.60387626 |
| 105 | detection of biotic stimulus (GO:0009595) | 2.59615492 |
| 106 | cellular response to interferon-gamma (GO:0071346) | 2.59536696 |
| 107 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.59399689 |
| 108 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.57937777 |
| 109 | NIK/NF-kappaB signaling (GO:0038061) | 2.57809610 |
| 110 | positive regulation of defense response to virus by host (GO:0002230) | 2.57584246 |
| 111 | negative regulation of innate immune response (GO:0045824) | 2.57383840 |
| 112 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.57091590 |
| 113 | lymphocyte chemotaxis (GO:0048247) | 2.56845507 |
| 114 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.56264424 |
| 115 | detection of molecule of bacterial origin (GO:0032490) | 2.56033842 |
| 116 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.55642439 |
| 117 | cellular response to exogenous dsRNA (GO:0071360) | 2.53776017 |
| 118 | neutrophil activation (GO:0042119) | 2.51796889 |
| 119 | regulation of mononuclear cell migration (GO:0071675) | 2.50853552 |
| 120 | defense response to protozoan (GO:0042832) | 2.50844571 |
| 121 | cellular response to interferon-beta (GO:0035458) | 2.47503311 |
| 122 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.45620464 |
| 123 | regulation of interleukin-12 production (GO:0032655) | 2.43809994 |
| 124 | positive regulation of macrophage cytokine production (GO:0060907) | 2.41992825 |
| 125 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.41832302 |
| 126 | defense response to virus (GO:0051607) | 2.40381009 |
| 127 | regulation of macrophage chemotaxis (GO:0010758) | 2.39795636 |
| 128 | negative regulation of interleukin-17 production (GO:0032700) | 2.38695686 |
| 129 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.38322964 |
| 130 | regulation of gamma-delta T cell activation (GO:0046643) | 2.37033872 |
| 131 | response to lipoprotein particle (GO:0055094) | 2.37013407 |
| 132 | positive regulation of lipid storage (GO:0010884) | 2.36849428 |
| 133 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.35739219 |
| 134 | positive regulation of p38MAPK cascade (GO:1900745) | 2.35722657 |
| 135 | positive regulation of humoral immune response (GO:0002922) | 2.35417051 |
| 136 | reactive oxygen species biosynthetic process (GO:1903409) | 2.33234225 |
| 137 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.32889919 |
| 138 | B cell mediated immunity (GO:0019724) | 2.32748604 |
| 139 | cellular response to growth hormone stimulus (GO:0071378) | 2.32497287 |
| 140 | positive regulation of T cell cytokine production (GO:0002726) | 2.31509095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.13354757 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.09328249 |
| 3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.62067779 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.51802292 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.07136092 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.02623052 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.02200895 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85915087 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.83548462 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.81050691 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.71198534 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.67107737 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.54223312 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.47296559 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.43117291 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.12581837 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.12070831 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.03030981 |
| 19 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.99235692 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.96502439 |
| 21 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.89023472 |
| 22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.86459412 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.76242927 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.74408538 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.74115545 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.71743409 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68925046 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.66071416 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64435686 |
| 30 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.60215011 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58050467 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57335308 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.50711446 |
| 34 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50638909 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49222965 |
| 36 | MYC_22102868_ChIP-Seq_BL_Human | 1.45618366 |
| 37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45567105 |
| 38 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39087323 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.36973201 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.36463445 |
| 41 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.31670958 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28318521 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.27780907 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.27339531 |
| 45 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.26903693 |
| 46 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26242466 |
| 47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25221233 |
| 48 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.24297389 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23826709 |
| 50 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22498668 |
| 51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20231807 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20055106 |
| 53 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.19888299 |
| 54 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18726214 |
| 55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.17199498 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17098386 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16323547 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16286991 |
| 59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16189205 |
| 60 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.15401650 |
| 61 | * MYB_26560356_Chip-Seq_TH2_Human | 1.15315924 |
| 62 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.14124031 |
| 63 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14064859 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12389663 |
| 65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11819647 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10198519 |
| 67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09411453 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09140503 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07038922 |
| 70 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.06595653 |
| 71 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.06595653 |
| 72 | MYB_26560356_Chip-Seq_TH1_Human | 1.05954998 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05903104 |
| 74 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05637160 |
| 75 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05158331 |
| 76 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04415958 |
| 77 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03563502 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03328474 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03130433 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03062886 |
| 81 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01651588 |
| 82 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00333890 |
| 83 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00077201 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99673987 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99001759 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97454834 |
| 87 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.96946165 |
| 88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96494230 |
| 89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93738428 |
| 90 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92904935 |
| 91 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92521540 |
| 92 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.92186521 |
| 93 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91758853 |
| 94 | UTX_26944678_Chip-Seq_JUKART_Human | 0.91590370 |
| 95 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.91556320 |
| 96 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91324339 |
| 97 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89284381 |
| 98 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.89195319 |
| 99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.88443497 |
| 100 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88213456 |
| 101 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.87921657 |
| 102 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87679251 |
| 103 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87378097 |
| 104 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86879693 |
| 105 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86187450 |
| 106 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85446105 |
| 107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85377612 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84926064 |
| 109 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.84546796 |
| 110 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.84366817 |
| 111 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84343655 |
| 112 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83581723 |
| 113 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82986139 |
| 114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82986139 |
| 115 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.82948670 |
| 116 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81921789 |
| 117 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.81154693 |
| 118 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80873405 |
| 119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80873405 |
| 120 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.80468384 |
| 121 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.80325426 |
| 122 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79144357 |
| 123 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78680724 |
| 124 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78465244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.60851220 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.35083757 |
| 3 | MP0003303_peritoneal_inflammation | 3.20614703 |
| 4 | MP0004510_myositis | 3.01375300 |
| 5 | MP0009785_altered_susceptibility_to | 2.92688433 |
| 6 | MP0003436_decreased_susceptibility_to | 2.90339006 |
| 7 | MP0006082_CNS_inflammation | 2.79909760 |
| 8 | MP0003724_increased_susceptibility_to | 2.76382628 |
| 9 | MP0001790_abnormal_immune_system | 2.64792811 |
| 10 | MP0005387_immune_system_phenotype | 2.64792811 |
| 11 | MP0000685_abnormal_immune_system | 2.48329644 |
| 12 | MP0002419_abnormal_innate_immunity | 2.47783817 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.40767036 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.38563072 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.38559152 |
| 16 | MP0005025_abnormal_response_to | 2.34505271 |
| 17 | MP0009840_abnormal_foam_cell | 2.33695069 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.29854560 |
| 19 | MP0005451_abnormal_body_composition | 2.22883059 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.08172674 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.05329149 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.01849306 |
| 23 | MP0004947_skin_inflammation | 2.00448958 |
| 24 | MP0001800_abnormal_humoral_immune | 1.99576005 |
| 25 | MP0002723_abnormal_immune_serum | 1.95118168 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.84403891 |
| 27 | MP0005671_abnormal_response_to | 1.82005944 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.78833153 |
| 29 | MP0003075_altered_response_to | 1.78778604 |
| 30 | MP0000604_amyloidosis | 1.78618953 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.76057825 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.73170872 |
| 33 | MP0005167_abnormal_blood-brain_barrier | 1.69855663 |
| 34 | MP0001819_abnormal_immune_cell | 1.66753726 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.62084267 |
| 36 | MP0008469_abnormal_protein_level | 1.62020102 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.61532364 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.61135018 |
| 39 | MP0003690_abnormal_glial_cell | 1.59767494 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.56699790 |
| 41 | MP0009764_decreased_sensitivity_to | 1.56690758 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.54471548 |
| 43 | MP0009278_abnormal_bone_marrow | 1.53635903 |
| 44 | MP0002006_tumorigenesis | 1.52466218 |
| 45 | MP0003045_fibrosis | 1.51850391 |
| 46 | MP0005310_abnormal_salivary_gland | 1.51063963 |
| 47 | MP0005360_urolithiasis | 1.46036689 |
| 48 | MP0004858_abnormal_nervous_system | 1.41590162 |
| 49 | MP0008004_abnormal_stomach_pH | 1.39847720 |
| 50 | MP0000343_altered_response_to | 1.36578254 |
| 51 | MP0003448_altered_tumor_morphology | 1.35868459 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.35280756 |
| 53 | MP0006054_spinal_hemorrhage | 1.34406021 |
| 54 | MP0002332_abnormal_exercise_endurance | 1.30582960 |
| 55 | MP0008260_abnormal_autophagy | 1.29720376 |
| 56 | MP0002139_abnormal_hepatobiliary_system | 1.27387559 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.27309895 |
| 58 | MP0002405_respiratory_system_inflammati | 1.27221096 |
| 59 | MP0001853_heart_inflammation | 1.26447960 |
| 60 | MP0004130_abnormal_muscle_cell | 1.24619451 |
| 61 | MP0008438_abnormal_cutaneous_collagen | 1.23748968 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.23235637 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.20204834 |
| 64 | MP0005670_abnormal_white_adipose | 1.18837035 |
| 65 | MP0002254_reproductive_system_inflammat | 1.18772451 |
| 66 | MP0003091_abnormal_cell_migration | 1.17788214 |
| 67 | MP0003195_calcinosis | 1.16977222 |
| 68 | MP0002722_abnormal_immune_system | 1.15475614 |
| 69 | MP0000716_abnormal_immune_system | 1.15046090 |
| 70 | MP0005166_decreased_susceptibility_to | 1.11879574 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.08744612 |
| 72 | MP0005257_abnormal_intraocular_pressure | 1.07974000 |
| 73 | MP0000609_abnormal_liver_physiology | 1.05538568 |
| 74 | MP0010307_abnormal_tumor_latency | 1.05168144 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 1.03872240 |
| 76 | MP0001545_abnormal_hematopoietic_system | 1.03872240 |
| 77 | MP0005083_abnormal_biliary_tract | 1.03699413 |
| 78 | MP0003252_abnormal_bile_duct | 1.03073461 |
| 79 | MP0004883_abnormal_blood_vessel | 1.03068497 |
| 80 | MP0009763_increased_sensitivity_to | 1.02981533 |
| 81 | MP0003866_abnormal_defecation | 1.02423466 |
| 82 | MP0002933_joint_inflammation | 1.01513109 |
| 83 | MP0010329_abnormal_lipoprotein_level | 1.01255150 |
| 84 | MP0002398_abnormal_bone_marrow | 1.01159989 |
| 85 | MP0004808_abnormal_hematopoietic_stem | 0.99707873 |
| 86 | MP0004185_abnormal_adipocyte_glucose | 0.97620796 |
| 87 | MP0005390_skeleton_phenotype | 0.92967987 |
| 88 | MP0005164_abnormal_response_to | 0.92219759 |
| 89 | MP0001958_emphysema | 0.90402047 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 0.89321236 |
| 91 | MP0002429_abnormal_blood_cell | 0.86830502 |
| 92 | MP0010352_gastrointestinal_tract_polyps | 0.86056170 |
| 93 | MP0000703_abnormal_thymus_morphology | 0.86017587 |
| 94 | MP0000249_abnormal_blood_vessel | 0.85184697 |
| 95 | MP0001851_eye_inflammation | 0.85102647 |
| 96 | MP0000689_abnormal_spleen_morphology | 0.84787987 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.84772998 |
| 98 | MP0003279_aneurysm | 0.83628310 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.81251007 |
| 100 | MP0010234_abnormal_vibrissa_follicle | 0.80508033 |
| 101 | MP0001348_abnormal_lacrimal_gland | 0.79802614 |
| 102 | MP0002118_abnormal_lipid_homeostasis | 0.79532835 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.79355848 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.78888603 |
| 105 | MP0005165_increased_susceptibility_to | 0.78865047 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.78482716 |
| 107 | MP0003828_pulmonary_edema | 0.78123774 |
| 108 | MP0001873_stomach_inflammation | 0.77334072 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.76932650 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76677616 |
| 111 | MP0005023_abnormal_wound_healing | 0.76588751 |
| 112 | MP0000767_abnormal_smooth_muscle | 0.76578268 |
| 113 | MP0002168_other_aberrant_phenotype | 0.75518740 |
| 114 | MP0009643_abnormal_urine_homeostasis | 0.75240565 |
| 115 | MP0000371_diluted_coat_color | 0.75237819 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.74696396 |
| 117 | MP0003795_abnormal_bone_structure | 0.74550761 |
| 118 | MP0000858_altered_metastatic_potential | 0.74133632 |
| 119 | MP0005365_abnormal_bile_salt | 0.73719517 |
| 120 | MP0009765_abnormal_xenobiotic_induced | 0.72453333 |
| 121 | MP0004381_abnormal_hair_follicle | 0.71955609 |
| 122 | MP0008875_abnormal_xenobiotic_pharmacok | 0.71037035 |
| 123 | MP0001663_abnormal_digestive_system | 0.70807332 |
| 124 | MP0002090_abnormal_vision | 0.70760178 |
| 125 | MP0008874_decreased_physiological_sensi | 0.69898372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.03907527 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.84827917 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 4.69695833 |
| 4 | Autoimmune thrombocytopenia (HP:0001973) | 4.60739945 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.58161416 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.57039805 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 3.82616314 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.81796999 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 3.50135678 |
| 10 | T lymphocytopenia (HP:0005403) | 3.42030128 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.35584374 |
| 12 | Abnormality of T cell number (HP:0011839) | 3.33496515 |
| 13 | Myocardial infarction (HP:0001658) | 3.31696711 |
| 14 | Keratoconjunctivitis sicca (HP:0001097) | 3.30831135 |
| 15 | Abnormality of the nasal mucosa (HP:0000433) | 3.16013122 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.15523940 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.13540705 |
| 18 | Nasal polyposis (HP:0100582) | 3.12304157 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.11893335 |
| 20 | Gingivitis (HP:0000230) | 3.10575663 |
| 21 | Orchitis (HP:0100796) | 3.09563223 |
| 22 | Axonal loss (HP:0003447) | 3.09323247 |
| 23 | Chronic otitis media (HP:0000389) | 3.07359134 |
| 24 | Tetraparesis (HP:0002273) | 3.04018333 |
| 25 | Hematochezia (HP:0002573) | 3.02588320 |
| 26 | Keratoconjunctivitis (HP:0001096) | 3.01811611 |
| 27 | Complement deficiency (HP:0004431) | 3.01038443 |
| 28 | Loss of speech (HP:0002371) | 2.99538939 |
| 29 | Myositis (HP:0100614) | 2.96758161 |
| 30 | Recurrent skin infections (HP:0001581) | 2.95259925 |
| 31 | Recurrent fungal infections (HP:0002841) | 2.94963518 |
| 32 | Recurrent viral infections (HP:0004429) | 2.87214227 |
| 33 | Glomerulonephritis (HP:0000099) | 2.86406342 |
| 34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.84138074 |
| 35 | Vasculitis (HP:0002633) | 2.82308950 |
| 36 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.75255868 |
| 37 | Mucopolysacchariduria (HP:0008155) | 2.75255868 |
| 38 | Nephritis (HP:0000123) | 2.68526366 |
| 39 | Meningitis (HP:0001287) | 2.68159629 |
| 40 | Interstitial pulmonary disease (HP:0006530) | 2.65521431 |
| 41 | Abnormality of glycolipid metabolism (HP:0010969) | 2.65389331 |
| 42 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.65389331 |
| 43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.65389331 |
| 44 | Retrobulbar optic neuritis (HP:0100654) | 2.65305508 |
| 45 | Optic neuritis (HP:0100653) | 2.65305508 |
| 46 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.63209188 |
| 47 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.63209188 |
| 48 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.63209188 |
| 49 | Basal ganglia calcification (HP:0002135) | 2.55986296 |
| 50 | Thick nail (HP:0001805) | 2.55105905 |
| 51 | Prostate neoplasm (HP:0100787) | 2.52238112 |
| 52 | Periodontitis (HP:0000704) | 2.51303009 |
| 53 | Colitis (HP:0002583) | 2.47476523 |
| 54 | Abnormality of complement system (HP:0005339) | 2.43771708 |
| 55 | Pustule (HP:0200039) | 2.43745222 |
| 56 | Encephalitis (HP:0002383) | 2.43601460 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.37195372 |
| 58 | Abnormality of T cells (HP:0002843) | 2.36643894 |
| 59 | Esophageal varix (HP:0002040) | 2.36340526 |
| 60 | IgA deficiency (HP:0002720) | 2.36017767 |
| 61 | Leukocytosis (HP:0001974) | 2.35583238 |
| 62 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.35060712 |
| 63 | Osteolytic defects of the hand bones (HP:0009699) | 2.35060712 |
| 64 | Gangrene (HP:0100758) | 2.32161324 |
| 65 | Arterial thrombosis (HP:0004420) | 2.30966767 |
| 66 | Increased IgM level (HP:0003496) | 2.30413103 |
| 67 | Anorexia (HP:0002039) | 2.28588698 |
| 68 | Disinhibition (HP:0000734) | 2.26953024 |
| 69 | Stomatitis (HP:0010280) | 2.26637741 |
| 70 | Hemorrhage of the eye (HP:0011885) | 2.26465111 |
| 71 | Amyloidosis (HP:0011034) | 2.26038791 |
| 72 | Gingival bleeding (HP:0000225) | 2.23326683 |
| 73 | Abnormality of the pericardium (HP:0001697) | 2.22019294 |
| 74 | Gastrointestinal infarctions (HP:0005244) | 2.19681449 |
| 75 | Chest pain (HP:0100749) | 2.19072188 |
| 76 | Hypergammaglobulinemia (HP:0010702) | 2.18031419 |
| 77 | Increased IgE level (HP:0003212) | 2.16373570 |
| 78 | Spontaneous hematomas (HP:0007420) | 2.16326901 |
| 79 | Cellulitis (HP:0100658) | 2.12950057 |
| 80 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.11908258 |
| 81 | Recurrent cutaneous fungal infections (HP:0011370) | 2.11194823 |
| 82 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.11194823 |
| 83 | Cerebral aneurysm (HP:0004944) | 2.10640425 |
| 84 | Joint hemorrhage (HP:0005261) | 2.09300676 |
| 85 | Asymmetric septal hypertrophy (HP:0001670) | 2.09149358 |
| 86 | Spondylolisthesis (HP:0003302) | 2.07397924 |
| 87 | Xanthomatosis (HP:0000991) | 2.07273793 |
| 88 | Porencephaly (HP:0002132) | 2.06168740 |
| 89 | Abnormality of the pleura (HP:0002103) | 2.04198034 |
| 90 | Frequent falls (HP:0002359) | 2.04098486 |
| 91 | Abnormality of the endocardium (HP:0004306) | 2.03601223 |
| 92 | Increased serum ferritin (HP:0003281) | 2.02755448 |
| 93 | Autoimmune hemolytic anemia (HP:0001890) | 2.02589959 |
| 94 | Polycythemia (HP:0001901) | 2.02539962 |
| 95 | Hand muscle atrophy (HP:0009130) | 2.02176244 |
| 96 | Gastrointestinal stroma tumor (HP:0100723) | 2.00932552 |
| 97 | Progressive visual loss (HP:0000529) | 2.00131273 |
| 98 | Eosinophilia (HP:0001880) | 1.99650011 |
| 99 | Joint swelling (HP:0001386) | 1.99122986 |
| 100 | Chronic diarrhea (HP:0002028) | 1.98881380 |
| 101 | Upper limb amyotrophy (HP:0009129) | 1.97389465 |
| 102 | Distal upper limb amyotrophy (HP:0007149) | 1.97389465 |
| 103 | Pulmonary embolism (HP:0002204) | 1.96454887 |
| 104 | Mitral stenosis (HP:0001718) | 1.96074567 |
| 105 | Peritonitis (HP:0002586) | 1.94024747 |
| 106 | Polyneuropathy (HP:0001271) | 1.93748011 |
| 107 | Arthralgia (HP:0002829) | 1.93092461 |
| 108 | Recurrent bronchitis (HP:0002837) | 1.92711442 |
| 109 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.91867527 |
| 110 | Cheilitis (HP:0100825) | 1.91164667 |
| 111 | Inflammation of the large intestine (HP:0002037) | 1.90949490 |
| 112 | Urticaria (HP:0001025) | 1.90369545 |
| 113 | Hypercholesterolemia (HP:0003124) | 1.90261294 |
| 114 | Granulocytopenia (HP:0001913) | 1.90076325 |
| 115 | Epistaxis (HP:0000421) | 1.90074099 |
| 116 | Deep venous thrombosis (HP:0002625) | 1.89041592 |
| 117 | Bone pain (HP:0002653) | 1.88597277 |
| 118 | Abnormality of T cell physiology (HP:0011840) | 1.88406316 |
| 119 | Hydroxyprolinuria (HP:0003080) | 1.88248150 |
| 120 | Abnormality of proline metabolism (HP:0010907) | 1.88248150 |
| 121 | Increased CSF protein (HP:0002922) | 1.88135603 |
| 122 | Hemoptysis (HP:0002105) | 1.88065284 |
| 123 | Keratitis (HP:0000491) | 1.88047861 |
| 124 | Osteomyelitis (HP:0002754) | 1.87638771 |
| 125 | Restrictive lung disease (HP:0002091) | 1.87025702 |
| 126 | Glomerulopathy (HP:0100820) | 1.86851096 |
| 127 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86363319 |
| 128 | Lymphopenia (HP:0001888) | 1.83890082 |
| 129 | Emphysema (HP:0002097) | 1.82326862 |
| 130 | Obstructive lung disease (HP:0006536) | 1.82104360 |
| 131 | Chronic obstructive pulmonary disease (HP:0006510) | 1.82104360 |
| 132 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.81801521 |
| 133 | Abnormality of the periventricular white matter (HP:0002518) | 1.80595197 |
| 134 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.79645305 |
| 135 | Abnormality of the peritoneum (HP:0002585) | 1.78619134 |
| 136 | Gastrointestinal inflammation (HP:0004386) | 1.76868053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TYK2 | 3.72326375 |
| 2 | TBK1 | 3.28338747 |
| 3 | MAP3K14 | 3.24210538 |
| 4 | PRPF4B | 2.96857878 |
| 5 | IKBKE | 2.85576293 |
| 6 | JAK1 | 2.83944795 |
| 7 | ERN1 | 2.62383994 |
| 8 | TAOK3 | 2.52089995 |
| 9 | JAK3 | 2.46480519 |
| 10 | RIPK4 | 2.36773172 |
| 11 | FGFR4 | 2.34334827 |
| 12 | EPHB1 | 2.29600341 |
| 13 | MST1R | 2.25862050 |
| 14 | MAP3K13 | 2.24884039 |
| 15 | MAP4K1 | 2.13393994 |
| 16 | TAOK2 | 2.07647763 |
| 17 | RIPK1 | 2.00375461 |
| 18 | KIT | 1.99063162 |
| 19 | TRIB3 | 1.87754186 |
| 20 | CAMK1D | 1.80410986 |
| 21 | IRAK4 | 1.74727941 |
| 22 | GRK7 | 1.72229573 |
| 23 | IKBKB | 1.66582971 |
| 24 | KSR2 | 1.61433089 |
| 25 | FGFR3 | 1.59501865 |
| 26 | BLK | 1.57856446 |
| 27 | IRAK3 | 1.51416468 |
| 28 | CSK | 1.51138221 |
| 29 | TTN | 1.47486259 |
| 30 | CAMK1G | 1.45428741 |
| 31 | TGFBR2 | 1.43848288 |
| 32 | TAOK1 | 1.43332611 |
| 33 | DDR2 | 1.40944091 |
| 34 | JAK2 | 1.39451850 |
| 35 | CDC42BPA | 1.34203103 |
| 36 | BMX | 1.26034295 |
| 37 | PTK6 | 1.24944415 |
| 38 | CHUK | 1.24627155 |
| 39 | EPHA3 | 1.22323131 |
| 40 | MAP3K2 | 1.17376334 |
| 41 | MAP3K11 | 1.17349943 |
| 42 | HCK | 1.09944093 |
| 43 | SIK3 | 1.04690406 |
| 44 | PKN2 | 1.04414575 |
| 45 | CSF1R | 1.03779654 |
| 46 | DAPK2 | 0.98064125 |
| 47 | CDK12 | 0.97626174 |
| 48 | SIK1 | 0.96270414 |
| 49 | FGR | 0.95613306 |
| 50 | ZAP70 | 0.94482209 |
| 51 | GRK6 | 0.90613465 |
| 52 | FES | 0.86674757 |
| 53 | RET | 0.86445829 |
| 54 | MAP3K1 | 0.85326953 |
| 55 | SYK | 0.83931171 |
| 56 | PRKD2 | 0.81374289 |
| 57 | STK10 | 0.80121956 |
| 58 | IRAK2 | 0.79277132 |
| 59 | PIK3CA | 0.78752939 |
| 60 | LCK | 0.77558832 |
| 61 | NME2 | 0.75831071 |
| 62 | MARK3 | 0.74589391 |
| 63 | MAP3K9 | 0.73788899 |
| 64 | DMPK | 0.73330301 |
| 65 | PBK | 0.72962793 |
| 66 | TXK | 0.72803911 |
| 67 | PRKCH | 0.69818241 |
| 68 | PTK2B | 0.67920343 |
| 69 | BMPR2 | 0.67430119 |
| 70 | MET | 0.67316609 |
| 71 | TEC | 0.66690919 |
| 72 | MAP3K10 | 0.66672807 |
| 73 | EGFR | 0.66653248 |
| 74 | CLK1 | 0.66316052 |
| 75 | PIM2 | 0.65919957 |
| 76 | SGK3 | 0.63551888 |
| 77 | PDPK1 | 0.61209720 |
| 78 | NEK9 | 0.60792439 |
| 79 | TRPM7 | 0.59439701 |
| 80 | CAMKK2 | 0.58935455 |
| 81 | MATK | 0.58826816 |
| 82 | PDK1 | 0.58713082 |
| 83 | ADRBK2 | 0.58686191 |
| 84 | MAPK7 | 0.56736014 |
| 85 | IRAK1 | 0.55257168 |
| 86 | MOS | 0.54689692 |
| 87 | SIK2 | 0.54666507 |
| 88 | MELK | 0.53094233 |
| 89 | TNK2 | 0.53015635 |
| 90 | LRRK2 | 0.52915803 |
| 91 | LYN | 0.51898922 |
| 92 | MAP3K5 | 0.49119262 |
| 93 | MARK2 | 0.49004762 |
| 94 | TLK1 | 0.48402384 |
| 95 | ABL1 | 0.48233834 |
| 96 | PRKCQ | 0.47664053 |
| 97 | PDGFRB | 0.47454908 |
| 98 | FRK | 0.46947309 |
| 99 | STK3 | 0.46343830 |
| 100 | PRKAA2 | 0.46263089 |
| 101 | ABL2 | 0.46238338 |
| 102 | ICK | 0.44391376 |
| 103 | PDGFRA | 0.43484184 |
| 104 | WNK1 | 0.43221450 |
| 105 | TIE1 | 0.42489217 |
| 106 | PKN1 | 0.40653799 |
| 107 | TESK2 | 0.40139381 |
| 108 | PIM1 | 0.39798260 |
| 109 | PIK3CG | 0.39565840 |
| 110 | BTK | 0.39485096 |
| 111 | MAPK11 | 0.39150033 |
| 112 | SMG1 | 0.38995646 |
| 113 | FYN | 0.37554003 |
| 114 | CAMKK1 | 0.37509112 |
| 115 | PRKD3 | 0.37176616 |
| 116 | MAP2K6 | 0.36541455 |
| 117 | ITK | 0.35726481 |
| 118 | MAPKAPK2 | 0.35699228 |
| 119 | MAP2K3 | 0.35216164 |
| 120 | RPS6KA4 | 0.34904926 |
| 121 | GSK3A | 0.34856932 |
| 122 | PRKCD | 0.34055043 |
| 123 | KDR | 0.32961311 |
| 124 | INSRR | 0.32399919 |
| 125 | CDK6 | 0.32323054 |
| 126 | YES1 | 0.32085617 |
| 127 | MAP3K3 | 0.31503859 |
| 128 | MAP2K1 | 0.31280405 |
| 129 | HIPK2 | 0.31055620 |
| 130 | MAP3K6 | 0.30006700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.12516240 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.65242025 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.50488275 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.08890618 |
| 5 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.96620742 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.90142490 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 1.87435133 |
| 8 | Influenza A_Homo sapiens_hsa05164 | 1.83511963 |
| 9 | Measles_Homo sapiens_hsa05162 | 1.76996352 |
| 10 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.72622262 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 1.71726892 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.71201587 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.69319695 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67819429 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.66236496 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.64809601 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63102503 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.61318611 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.53273537 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47533672 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.43813726 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.43369805 |
| 23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39468813 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.37484865 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.37288172 |
| 26 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.32514864 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.31457633 |
| 28 | Hepatitis C_Homo sapiens_hsa05160 | 1.30427811 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.28938881 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.23547962 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20908782 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19332429 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.18395601 |
| 34 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.18267690 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18049369 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.17721121 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.15379946 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.15259216 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.15045153 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09088110 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.08090174 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.08003385 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05264928 |
| 44 | Amoebiasis_Homo sapiens_hsa05146 | 1.01898632 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.01472115 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99464834 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.98897721 |
| 48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.96228056 |
| 49 | Prion diseases_Homo sapiens_hsa05020 | 0.95510927 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 0.95330773 |
| 51 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.95229833 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94370985 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.89527247 |
| 54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89121300 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.88666340 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.88494927 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.86887490 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86383962 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.84054561 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82920761 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 0.79007308 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.78533073 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77706863 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76869460 |
| 65 | Bladder cancer_Homo sapiens_hsa05219 | 0.76048592 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.75986427 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74692784 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73705269 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73640824 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72657069 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72243318 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70976565 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69054173 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68147659 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65317401 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.64127321 |
| 77 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63306046 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63275245 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.62844190 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61255611 |
| 81 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61135865 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.60852917 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60491813 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59360266 |
| 85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56111985 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55685550 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55104284 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53976417 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49031152 |
| 90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48535490 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48493045 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46001371 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45759981 |
| 94 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.44497547 |
| 95 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44473607 |
| 96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43026185 |
| 97 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.42999072 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42978295 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.42651094 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41098133 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40637558 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40336779 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.40146443 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38525256 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38361708 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38297082 |
| 107 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.37950502 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37202955 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37064443 |
| 110 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.36890625 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36392917 |
| 112 | Focal adhesion_Homo sapiens_hsa04510 | 0.36187919 |
| 113 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33410133 |
| 114 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32506290 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31726180 |
| 116 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.31343405 |
| 117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29932328 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29866188 |
| 119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28599813 |
| 120 | Adherens junction_Homo sapiens_hsa04520 | 0.27929939 |

